ARDT (Ardent Health, Inc.) Stock Analysis - Politician Trades

Ardent Health, Inc. (ARDT) is a publicly traded Healthcare sector company. As of May 21, 2026, ARDT trades at $9.45 with a market cap of $1.45B and a P/E ratio of 9.87. ARDT moved -3.57% today. Year to date, ARDT is +5.70%; over the trailing twelve months it is -37.54%. Its 52-week range spans $8.07 to $20.72. Analyst consensus is buy with an average price target of $12.59. Rallies surfaces ARDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ARDT stock?

Rallies tracks politician and congressional stock disclosures for ARDT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

ARDT Key Metrics

Key financial metrics for ARDT
MetricValue
Price$9.45
Market Cap$1.45B
P/E Ratio9.87
EPS$0.96
Dividend Yield0.00%
52-Week High$20.72
52-Week Low$8.07
Volume10
Avg Volume0
Revenue (TTM)$6.32B
Net Income$230.13M
Gross Margin0.00%

Latest ARDT News

Recent ARDT Insider Trades

  • Webb Robert Thomas bought 10.00K (~$174.70K) on Nov 8, 2024.
  • Webb Robert Thomas bought 10.00K (~$164.90K) on Nov 8, 2024.

ARDT Analyst Consensus

10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.59.

Common questions about ARDT

Which politicians traded ARDT stock?
Rallies tracks politician and congressional stock disclosures for ARDT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ARDT?
Yes. Rallies tracks politician and congressional stock disclosures for ARDT, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ARDT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARDT. It does not provide personalized investment advice.
ARDT

ARDT